Kolibri Global Energy's third quarter matched estimates, and the headline flatters how the quarter actually unfolded. Earnings Whispers puts adjusted earnings at $0.15 per share, exactly matching consensus and up 36.4% from a year ago. Revenue of $18.37 million beat the $17.26 million consensus by 6.4% and grew 20.9% year over year.

That growth came almost entirely from price. Kolibri realized $64.98 per BOE, up 34%, while average production fell 9% to 3,867 BOE per day. The call summary cited 3,876, a minor discrepancy. Revenue also decelerated: the 22% year-over-year gain in net revenue was half the 43% pace for the first nine months. Sequentially, the quarter was clearly a trough:

• Revenue fell from $22.5 million in Q2.
• Adjusted EBITDA fell from $16.4 million to $13.3 million.
• Net income dropped from $8.5 million to $3.6 million.
• Production was well below the roughly 4,690 BOE/d run rate of the first half.

The quality of the quarter deserves scrutiny. On a GAAP basis, EPS was $0.10, flat with the prior year, and net income edged down 1%. That gap with the adjusted figure reflects a $2.4 million unrealized loss on commodity contracts plus a $1.0 million realized hedge loss. The realized loss alone cost $2.93 per BOE, so the hedge book is visibly muting Kolibri's leverage to $85 oil.

Operating costs also remain sticky. Opex was $8.39 per BOE, an improvement from $8.90 in Q2 but still well above the 2025 average of about $7.33. Management attributed the increase to severance taxes, chemicals and a non-operated workover. Netback from operations still rose 41% to $43.48 per BOE (the call summary cited $42.48), but that is a price story, not an efficiency story.

The call shifted attention to what comes next, and here management's tone was noticeably more confident. The first test of the False Caney bench (spelled "Falls Caney" in the call summary) is averaging 636 BOE/d, about 545 barrels of which are oil. Management reported "zero complaints" with the well. The interval reportedly spans most of the acreage and carries no booked reserves, so success there could expand both inventory and reserves. Two quarters ago it was only a pre-drill hypothesis backed by core data.

The three Clifton Mack wells are adding about 1,911 BOE/d, lifting current output to roughly 5,700 BOE/d. That is about 47% above the Q3 average and sets up what management expects to be a record fourth quarter. Management is also framing a 2027 base program with upside cases.

Bears still have legitimate ammunition:

• **Guidance:** Full-year production guidance has drifted to "probably the lower end" of the range because a well came on late. Last quarter, management declined to lean either way.
• **Product mix:** The new southwest wells are gassier than expected, pressuring the oil mix.
• **Unproven decline:** False Caney decline behavior is still unknown this early in the well's life.
• **Leverage:** The call's deleveraging claim needs reconciliation. It cited net debt falling to $15.4 million from $45 million at Q1, yet the balance sheet shows loans and borrowings rising to $54.8 million from $48.8 million at year-end. Available borrowing capacity also fell from $30.5 million in June to $19.5 million in September, while working capital remains about $12.6 million negative. The reaffirmed $75 million borrowing base helps, but investors should not take the leverage improvement at face value without that reconciliation.

Investors were already cooling before the print. Earnings Whispers sentiment slid from -0.11 to -0.38, a meaningful deterioration deeper into negative territory. The stock traced a sharp round trip:

• It ran to a 52-week high of $7.37 on October 27, likely on the well announcements.
• It fell to $5.01 by November 10.
• It entered the report at $5.56, 24.6% below that peak.

That leaves shares only 0.9% above where they opened after the August report and just 2.4% above the $5.43 200-day moving average. Most of the October enthusiasm has been surrendered. The internal trend readings are mixed, with momentum positive but the AVWAP trend negative, consistent with a stock that spiked and then faded.

The bottom line is that Kolibri delivered an in-line, price-driven quarter that marks the low point for volumes. The investment case now rests on the fourth quarter. A 5,700 BOE/d run rate and a potentially reserve-expanding new bench offer a credible path to record results. However, hedge drag, elevated costs, a gassier mix and low-end guidance argue that execution, not commodity prices, must carry the stock back toward its October highs.